Vnitr Lek 2024, 70(2):120-125 | DOI: 10.36290/vnl.2024.024

Suspicion of a hypervitaminosis A during acitretin therapy

Markéta Kobzová, Pavel Polák
Interní oddělení, Vojenská nemocnice Brno

The authors present a clinical case of a 90 years old woman treated with acitretin for psoriasis during past two years, in whom develloped spontaneously haemorrhagic blisters on extremities, on oral mucosal surfaces and large subcutaneous hematomas. In the differential diagnostic work-up an allergy to co-trimoxazole, plazmocellular neoplasia, amyloidosis and bacterial endocarditis were suspected. Both microscopic evaluation as microbial cultivation of the aspirated hemorrhagic fluid were concluded as contamination. There were no signs of paraproteinemia in serum immunoelektrophoresis study. Extended medical history revealed till months persisting xerophthlamia, xerostomia, nail fragility and hair loss, which all are consistent with hypervitaminosis A. The bleeding signs subsided within several days after acitretin withdrawal. Both the drug serum concentrations and retinol concentrations were not performed.

Keywords: acitretin, hypervitaminosis A, bleeding.

Accepted: March 26, 2024; Published: April 10, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kobzová M, Polák P. Suspicion of a hypervitaminosis A during acitretin therapy. Vnitr Lek. 2024;70(2):120-125. doi: 10.36290/vnl.2024.024.
Download citation

References

  1. Kamenská M. Hypo/hypervitaminózy. Část 2, vitaminy rozpustné v tucích. Med praxi. 2023;20(3):180-184. Go to original source...
  2. Carazo A, Macáková K, Matoušová K, et al. Vitamin A update: forms, sources, kinetics, detection, function, deficiency, therapeutic use and toxicity. Nutrients 2021; 13:1703. doi.org/10.3390/nu13051703. Go to original source... Go to PubMed...
  3. Nast A, Smith C, Spuls RI, et al. EuroGuiDerm guideline on the systemic treatment of psoriasis vulgaris - Part 1: treatment and monitoring recommendations. J Eur Acad Dermatol Venereol. 2020;34:2461-2498. doi: 10.1111/jdv.16915. Go to original source... Go to PubMed...
  4. Sbidian E. Acitrétine. 2019. pp. 1-12. Available from: https://www.sciencedirect.com/science/article/pii/S0151963819301425
  5. Masopust J, Řeháček V, Turek P, et al. Posuzování způsobilosti k dárcovství krve a krevních složek verze 10, 2022_07_28 1 z 19 Doporučení Společnosti pro transfuzní lékařství ČLS JEP č. STL2007_03, verze 10 (2022_07_28). Available from: https://transfuznispolecnost.cz/doporucene-postupy#file-accordion-doporucene-postupy-stl
  6. Castaño G, Etchart C, Sookoian S. Vitamin A toxicity in a physical culturist patient: A case report and review of the literature. Ann Hepatol. 2006;5(4):293-295. Go to original source...
  7. Miksad R, de Lédinghen V, McDougall C, et al. Hepatic hydrothorax associated with vitamin a toxicity. J Clin Gastroenterol. 2002;34(3):275-279. doi: 10.1097/00004836-200203000-00017. Go to original source... Go to PubMed...
  8. Daher EDF, Martiniano LVM, Lima LLL, et al. Acute kidney injury due to excessive and prolonged intramuscular injection of veterinary supplements containing vitamins A D and E: A series of 16 cases. Nefrologia. 2017;37(1):61-67. doi: 10.1016/j.nefro.2016.05.017. Go to original source... Go to PubMed...
  9. Perrotta S, Nobili B, Rossi F. Infant hypervitaminosis A causes severe anemia and thrombocytopenia: evidence of a retinol-dependent bone marrow cell growth inhibition. Blood 2002;99:2017-2022. doi: 10.1182/blood.v99.6.2017. Go to original source... Go to PubMed...
  10. Bucciol G, Cassiman D, Roskams T, et al. Liver transplantation for very severe hepatopulmonary syndrome due to vitamin A-induced chronic liver disease in a patient with Schwachman-Diamond syndrome. Orphanet J Rare Dis. 2018;13(1):69. doi: 10.1186/s13023-018-0818-2. Go to original source... Go to PubMed...
  11. Azzam R, Dilley K, Melin-Aldana H, et al. Clinical Quiz. J Ped Gastroenterol Nutr. 2005;41(3):363-365. doi: 10.1097/01.MPG.0000145793.78028.9E. Go to original source... Go to PubMed...
  12. Ito T, Nemoto M. Kupfer´s cells and fat storing cells in the capillary wall of human liver. Okajimas Folia Anat Jpn. 1952;24(4):243-258. doi: 10.2535/ofaj1936.24.4_243. Go to original source... Go to PubMed...
  13. Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27-42. doi:10.1016/j.addr.2017.05.007. Go to original source... Go to PubMed...
  14. Hruban Z, Russel R, Boyer JL, et al. Ultrastructural changes in livers of two patients with hypervitaminosis A. Am J Pathol. 1974;76:451-468.
  15. Schmitt C, Domangé B, Torrents R, et al. Hypervitaminosis A following the ingestion of fish liver: report on 3 cases from the Poison Control Center in Marseille. Wilderness Environ Med. 2020;31(4):454-456. doi: 10.1016/j.wem.2020.06.003. Go to original source... Go to PubMed...
  16. Zavattaro E, Celasco M, Delrosso G, et al. Acitretin-induced acral hemorrhagic lesions in Darier-White disease. Cutis. 2014;94(6): E1-5.
  17. Fairhurst DA, Clark SM. Rectal bleeding following acitretin therapy for discoid lupus erythematosus. Dermatology. 2005;211(4):385. doi: 10.1159/000088519. Go to original source... Go to PubMed...
  18. Aydogan K, Karadogan SK, Tunali S. Acitretin-induced subungual hemorrhage. Int J Dermatol. 2007;46(5):494-495. doi: 10.1111/j.1365-4632.2006.03059.x. Go to original source... Go to PubMed...
  19. Thomas M, Shon W, Truong A. Acitretin-induced periungual pyogenic granulomas and review. Dermatol Online J. 2021;27(7): 9. doi: 10.5070/D327754369. Go to original source... Go to PubMed...
  20. G Carretero , M Ribera, I Belinchón, et. al. Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology, Actas Dermosifiliogr.2013 Sep;104(7):598-616. doi: 10.1016/j.adengl.2013.01.001 Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.